Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

Background: Cannabidiol (CBD) is a cannabinoid of potential interest for the treatment of substance use disorders. Our aim was to review the outcome measures, surrogate endpoints, and biomarkers in published and ongoing randomized clinical trials.Methods: We conducted a search in PubMed, Web of Scie...

Full description

Bibliographic Details
Main Authors:	Alix Morel, Pierre Lebard, Alexandra Dereux, Julien Azuar, Frank Questel, Frank Bellivier, Cynthia Marie-Claire, Mélina Fatséas, Florence Vorspan, Vanessa Bloch
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Psychiatry
Subjects:	cannabis tobacco opioid clinical trials cannabinoids cannabidiol
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2021.565617/full

Similar Items

Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review
by: Margaux Poireau, et al.
Published: (2022-07-01)

Patients With Severe Alcohol-Related Cognitive Impairment Improve in Flexibility When Abstinence Is Maintained: A Comparative Study With Alzheimer’s Disease
by: Virgile Clergue-Duval, et al.
Published: (2022-07-01)

Ascorbic Acid Deficiency Prevalence and Associated Cognitive Impairment in Alcohol Detoxification Inpatients: A Pilot Study
by: Virgile Clergue-Duval, et al.
Published: (2021-11-01)

Using density of antecedent events and trajectory path analysis to investigate family-correlated patterns of onset of bipolar I disorder: a comparison of cohorts from Europe and USA
by: Jan Scott, et al.
Published: (2021-10-01)

Correction to: Using density of antecedent events and trajectory path analysis to investigate family-correlated patterns of onset of bipolar I disorder: a comparison of cohorts from Europe and USA
by: Jan Scott, et al.
Published: (2021-10-01)

Risk and Protective Factors of Lifetime Cocaine-Associated Chest Pain
by: Virgile Clergue-Duval, et al.
Published: (2021-07-01)

Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study
by: Grégoire Cleirec, et al.
Published: (2018-10-01)

Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders
by: Norman Therribout, et al.
Published: (2022-06-01)

Clustering suicidal phenotypes and genetic associations with brain-derived neurotrophic factor in patients with substance use disorders
by: Romain Icick, et al.
Published: (2021-01-01)

A single case report of STN-DBS for severe crack-cocaine dependence: double-blind ON vs. SHAM randomized controlled assessment
by: Florence Vorspan, et al.
Published: (2023-05-01)

Alcohol Withdrawal Is an Oxidative Stress Challenge for the Brain: Does It Pave the Way toward Severe Alcohol-Related Cognitive Impairment?
by: Virgile Clergue-Duval, et al.
Published: (2022-10-01)

A specific cognitive behavioral group therapy program for stimulant use disorder
by: Emily Karsinti, et al.
Published: (2022-11-01)

Editorial: Dual disorders (addictive and concomitant psychiatric disorders): Mechanisms and treatment
by: Florence Vorspan, et al.
Published: (2022-08-01)

Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users
by: Julien Cabé, et al.
Published: (2021-11-01)

Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
by: Cynthia Marie-Claire, et al.
Published: (2022-01-01)

A Comparison of Different Approaches to Clinical Phenotyping of Lithium Response: A Proof of Principle Study Employing Genetic Variants of Three Candidate Circadian Genes
by: Jan Scott, et al.
Published: (2021-10-01)

Associations between circadian misalignment and telomere length in BD: an actigraphy study
by: Luana Spano, et al.
Published: (2022-05-01)

The Impact of Co-occurring Post-traumatic Stress Disorder and Substance Use Disorders on Craving: A Systematic Review of the Literature
by: Fabien Renaud, et al.
Published: (2021-12-01)

Cure-All cannabidiol? The cannabidiol content of commercial products
by: Michaela Mouton, et al.
Published: (2024-02-01)

Should problematic sexual behavior be viewed under the scope of addiction? A systematic review based on DSM-5 substance use disorder criteria
by: Natasha Pistre, et al.
Published: (2023-12-01)

An evidence map of actigraphy studies exploring longitudinal associations between rest-activity rhythms and course and outcome of bipolar disorders
by: Jan Scott, et al.
Published: (2020-12-01)

Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder
by: Nadia Cattane, et al.
Published: (2022-10-01)

Which Actigraphy Dimensions Predict Longitudinal Outcomes in Bipolar Disorders?
by: Lisa Ferrand, et al.
Published: (2022-04-01)

Cannabidiol use and perceptions in France: a national survey
by: Clémence Casanova, et al.
Published: (2022-08-01)

Use and knowledge of contraceptive methods by patients in two substance use disorders treatment centers in Paris
by: Virgile Clergue-Duval, et al.
Published: (2017-08-01)

Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome
by: Béatrice Desnous, et al.
Published: (2024-02-01)

The Psycho-Affective Roots of Obesity: Results from a French Study in the General Population
by: Lena Bourdier, et al.
Published: (2020-09-01)

Cognitive and Interpersonal Factors in Adolescent Inpatients with Anorexia Nervosa: A Network Analysis
by: Chantal P. Delaquis, et al.
Published: (2023-04-01)

Cannabidiol, from Past to Present: a Review
by: Andra Popescu, Alexandra Dreanca, Orsolya Sarpataki, Mihai Cernea, Aurelia Jourdan, Ioan Marcus
Published: (2023-06-01)

Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)
by: Alexander C. S. Thomson, et al.
Published: (2024-04-01)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
by: Gabriel A. Garcia, et al.
Published: (2022-07-01)

Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetrahydrocannabinol and Cannabidiol for Treatment of Chronic Back or Neck Pain: A Multiple-Dose Escalation Study
by: Paul Glare, et al.
Published: (2023-07-01)

Evaluation of the efficacy of a cannabidiol and cannabidiolic acid rich hemp extract for pain in dogs following a tibial plateau leveling osteotomy
by: Sarah Klatzkow, et al.
Published: (2023-01-01)

Pharmacokinetics of cannabidiol-/cannabidiolic acid-rich hemp oil in juvenile cynomolgus macaques (Macaca fascicularis)
by: Tinika N. Johns, et al.
Published: (2023-11-01)

The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study
by: Julien Rossignol, et al.
Published: (2023-02-01)

Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study
by: Romain Icick, et al.
Published: (2022-05-01)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
by: Gustavo Gonzalez-Cuevas, et al.
Published: (2021-10-01)

THE IMPLEMENTATION OF DISCUSSION METHOD THROUGH ZOOM MEETING FOR PKN LEARNING DURING THE PANDEMIC PERIOD
by: Azuar Azuar
Published: (2021-05-01)

Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke
by: Erika Meyer, et al.
Published: (2022-10-01)

The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer’s Disease
by: Václav Trojan, et al.
Published: (2023-09-01)